계명대학교 의학도서관 Repository

Safety and efficacy of a novel hyperaemic agent, intracoronary nicorandil, for invasive physiological assessments in the cardiac catheterization laboratory

Metadata Downloads
Author(s)
Ho-Jun JangBon-Kwon KooHee-Sun LeeJun-Bean ParkJi-Hyun KimMyung-Ki SeoHan-Mo YangKyung-Woo ParkChang-Wook NamJoon-Hyung DohHyo-Soo Kim
Keimyung Author(s)
Nam, Chang Wook
Department
Dept. of Internal Medicine (내과학)
Journal Title
European Heart Journal
Issued Date
2013
Volume
34
Issue
27
Abstract
Aims Maximal hyperaemia is a key element of invasive physiological studies and adenosine is the most commonly used
agent. However, infusion of adenosine requires additional venous access and can cause chest discomfort, bronchial
hyper-reactivity, and atrioventricular conduction block. The aim of this study was to evaluate the feasibility and efficacy
of intracoronary (IC) nicorandil as a novel hyperaemic agent for invasive physiological studies.
Methods
and results
We enrolled 210 patients who underwent fractional flow reserve (FFR) measurement. Hyperaemic efficacy of the
following methods was compared: IC bolus injection of adenosine; intravenous (i.v.) infusion of adenosine
(140 mg/kg/min); and IC bolus of nicorandil (1 and 2 mg). In 70 patients, the index of microcirculatory resistance
was also measured. Hyperaemic efficacy of IC nicorandil 2 mg was non-inferior to that of i.v. adenosine infusion
(FFR: 0.82+0.10 vs. 0.82+0.10; P for non-inferiority , 0.001). There was a strong correlation between FFRs measured
by i.v. adenosine and IC nicorandil (R2 ¼ 0.934). Nicorandil produced fewer changes in blood pressure, heart
rate and PR interval, and less chest pain than adenosine (all P-values , 0.05). Atrioventricular block occurred in 12
patients with IC adenosine, 4 patients with i.v. adenosine and none with IC nicorandil. The index of microcirculatory
resistance was 18.3+8.7 with i.v. adenosine and 17.2+7.6 with IC nicorandil (P ¼ 0.126).
Conclusion This study suggests that IC bolus injection of nicorandil is a simple, safe, and effective way to induce steady-state
hyperaemia for invasive physiological evaluations.
Clinicaltrials.gov number: NCT01331902.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Keywords Fractional flow reserve † Hyperaemia † Nicorandil
Keimyung Author(s)(Kor)
남창욱
Publisher
School of Medicine
Citation
Ho-Jun Jang et al. (2013). Safety and efficacy of a novel hyperaemic agent,
intracoronary nicorandil, for invasive
physiological assessments in the cardiac
catheterization laboratory. European Heart Journal, 34(27), 2055–2062. doi: 10.1093/eurheartj/eht040
Type
Article
ISSN
0195-668X
Source
http://lps3.academic.oup.com.proxy.dsmc.or.kr/eurheartj/article/34/27/2055/439733#89305581
DOI
10.1093/eurheartj/eht040
URI
https://kumel.medlib.dsmc.or.kr/handle/2015.oak/35649
Appears in Collections:
1. School of Medicine (의과대학) > Dept. of Internal Medicine (내과학)
공개 및 라이선스
  • 공개 구분공개
  • 엠바고Forever
파일 목록

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.